Kevin Campbell, PhD
Kevin P. Campbell, PhD, is an investigator with the Howard Hughes Medical Institute, the Roy J. Carver Biomedical Research Chair in Molecular Physiology and Biophysics, Executive Officer of the Department of Molecular Physiology and Biophysics, and Director of the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center at the Carver College of Medicine, University of Iowa. Dr. Campbell is internationally recognized for his discovery of dystroglycan, and for elucidation of its function as an extracellular matrix receptor. His work established that dystroglycan is involved in a variety of physiological and developmental processes, including maintenance of skeletal muscle function as well as formation and function of the central nervous system. He showed that complex post-translational processing of dystroglycan, including extensive glycosylation, is required for its ability to function as an extracellular matrix receptor and that abnormal glycosylation results in a variety of congenital and limb-girdle muscular dystrophies with or without associated defects in brain development and function.
Dr. Campbell is an elected member of the Institute of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences. In 2009, Dr. Campbell received the March of Dimes Prize in Developmental Biology for his pioneering research on cell mechanisms involved in muscular dystrophy. Dr. Campbell will receive the Society for Glycobiology President’s Innovator Award in the fall of 2017.